Cipher Pharmaceuticals Inc.

CPH.TOTSXHealthcare● Active

$16.90

+$0.06(+0.36%)

Market Cap$429113342

P/E Ratio—

52W High$20.56

52W Low$11.98

Avg Volume33K

Open$16.84

Beta0.48

Free Cash Flow Financials Revenue

Cipher Pharmaceuticals Inc. (CPH.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CPH.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

CPH.TO · FCF · TTM · margin & CAGR

Free cash flow was $30.2M for FY2025 (fiscal year ending 2025-12-31), up 54.9% year-over-year The FCF margin was 58.9%. Five-year CAGR stands at +22.6%.

FY2025 Free Cash Flow$30.2M▲ +54.9% YoY

Trailing 12M (TTM)$30.0Mtrailing 4 quarters sum

FCF Margin58.9%$30.2M ÷ revenue

3-Year CAGR+42.3%FY2022 → FY2025

5-Year CAGR+22.6%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CPH.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$30.2M(0M)$30.2M▲ +54.9%58.9%

FY2024$19.5M(0M)$19.5M▲ +22.1%58.5%

FY2023$16.0M(0M)$16.0M▲ +52.3%75.5%

FY2022$10.6M(0M)$10.5M▼ 24.0%50.8%

FY2021$13.8M(0M)$13.8M▲ +26.4%63.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CPH.TO · P/FCF · FCF yield · FCF per share

Cipher Pharmaceuticals Inc. (CPH.TO) trades at a FCF yield of 9.75% and a price-to-free-cash-flow ratio of 14.3x. FCF per share stands at $1.18, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

9.75%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.18

TTM FCF ÷ Shares Outstanding

Price / FCF

x14.3

Share Price ÷ FCF per Share

EV / FCF (TTM)

x10.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CPH.TO · cash flow statement · operating / investing / financing

For FY2025, Cipher Pharmaceuticals Inc. generated $30.2M in operating cash flow and spent 0M in capital expenditures, yielding $30.2M in free cash flow.

Operating Activities

+$30.2M

Cash from core business operations

2025-12-31

Investing Activities

−$0.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$41.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($30.2M) − |CapEx| (0M) = FCF ($30.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CPH.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Cipher Pharmaceuticals Inc.YOU

CPH.TO

$30.2M+54.9%58.9%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cipher Pharmaceuticals Inc. (CPH.TO) reported free cash flow of $30.2M for FY2025 (fiscal year ending 2025-12-31), up 54.9% year-over-year. The FCF margin was 58.9%.

Based on available data, Cipher Pharmaceuticals Inc. has maintained positive free cash flow for at least 13 fiscal year(s). FCF peaked at $30.2M in FY2025. The 5-year CAGR stands at +22.6%.

Cipher Pharmaceuticals Inc.'s FCF yield is 9.75% and price-to-FCF ratio is 14.3x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CPH.TO free cash flow · 8 questions

Cipher Pharmaceuticals Inc. free cash flow was $30.2M for FY2025, up 54.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $30.0M.

CPH.TO free cash flowCPH.TO FCFCPH.TO FCF 2025CPH.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Cipher Pharmaceuticals Inc. · Cipher Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026